DE3461803D1
(en)
*
|
1983-05-23 |
1987-02-05 |
Pfizer |
Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin a and intermediates therefor
|
US4464527A
(en)
*
|
1983-06-30 |
1984-08-07 |
Pfizer Inc. |
Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
|
DE3475073D1
(en)
*
|
1983-09-06 |
1988-12-15 |
Pfizer |
Azahomoerythromycin b derivatives and intermediates thereof
|
US4465674A
(en)
*
|
1983-09-06 |
1984-08-14 |
Pfizer Inc. |
Azahomoerythromycin D derivative and intermediates therefor
|
US4518590A
(en)
*
|
1984-04-13 |
1985-05-21 |
Pfizer Inc. |
9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
|
YU44599B
(en)
*
|
1986-09-12 |
1990-10-31 |
Pliva Pharm & Chem Works |
Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
|
UA27040C2
(uk)
*
|
1987-07-09 |
2000-02-28 |
Пфайзер Інк. |
Кристалічhий дигідрат азитроміциhу та спосіб одержаhhя кристалічhого дигідрату азитроміциhу
|
WO1989002271A1
(en)
*
|
1987-09-10 |
1989-03-23 |
Pfizer |
Azithromycin and derivatives as antiprotozoal agents
|
WO1989004167A1
(en)
*
|
1987-11-10 |
1989-05-18 |
Pfizer Inc. |
Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives
|
US5837691A
(en)
*
|
1988-08-03 |
1998-11-17 |
Schering Corporation |
Actinomadura vulgaris subsp vulgaris and antimicrobial complex and antimicrobial
|
SI9011409A
(en)
*
|
1990-07-18 |
1995-10-31 |
Pliva Pharm & Chem Works |
O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
|
US5912331A
(en)
*
|
1991-03-15 |
1999-06-15 |
Merck & Co., Inc. |
Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
CA2064634C
(en)
|
1991-04-04 |
1998-08-04 |
James V. Heck |
9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
|
US5189159A
(en)
*
|
1992-04-02 |
1993-02-23 |
Merck & Co., Inc. |
8a-AZA-8a-homoerythromycin cyclic iminoethers
|
US5215980A
(en)
*
|
1992-01-17 |
1993-06-01 |
Merck & Co., Inc. |
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
|
TW271400B
(da)
*
|
1992-07-30 |
1996-03-01 |
Pfizer |
|
US5210235A
(en)
*
|
1992-08-26 |
1993-05-11 |
Merck & Co., Inc. |
Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
|
HRP930014A2
(en)
*
|
1993-01-08 |
1994-08-31 |
Pliva Pharm & Chem Works |
9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
|
US5332807A
(en)
*
|
1993-04-14 |
1994-07-26 |
Merck & Co., Inc. |
Process of producing 8A- and 9A-azalide antibiotics
|
DE69403963T2
(de)
*
|
1993-05-19 |
1997-11-20 |
Pfizer |
Zwischenprodukt für azithromycin
|
US5441939A
(en)
*
|
1994-03-04 |
1995-08-15 |
Pfizer Inc. |
3"-desmethoxy derivatives of erythromycin and azithromycin
|
HRP940251B1
(en)
*
|
1994-04-15 |
1998-12-31 |
Stjepan Mutak |
Process for the preparation of azithromycin dihydrochloride
|
US5605889A
(en)
*
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
RO114740B1
(ro)
*
|
1994-05-06 |
1999-07-30 |
Pfizer |
Compozitie cu eliberare controlata, procedeu de obtinere a acesteia si metoda de tratament
|
PT102006B
(pt)
*
|
1997-05-19 |
2000-06-30 |
Hovione Sociedade Quimica S A |
Novo processo de preparacao de azitromicina
|
HN1998000086A
(es)
*
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
HN1998000074A
(es)
*
|
1997-06-11 |
1999-01-08 |
Pfizer Prod Inc |
Derivados de macrolidos c-4 sustituidos
|
JP2003512290A
(ja)
*
|
1997-09-10 |
2003-04-02 |
メルク エンド カムパニー インコーポレーテッド |
家畜抗菌剤としての8a−アザライド
|
PT1437359E
(pt)
*
|
1997-10-16 |
2007-04-30 |
Glaxosmithkline Zagreb |
Novos 3,6-hemicetais da classe dos 9a-azalidos
|
US6861411B1
(en)
*
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
PT925789E
(pt)
*
|
1997-12-02 |
2004-10-29 |
Pfizer Prod Inc |
Es oculares utilizacao de azitromicina no tratamento topico de infecco
|
AP1060A
(en)
|
1998-01-02 |
2002-04-23 |
Pfizer Prod Inc |
Novel erythromycin derivatives.
|
AP9801420A0
(en)
*
|
1998-01-02 |
1998-12-31 |
Pfizer Prod Inc |
Novel macrolides.
|
TW546302B
(en)
*
|
1998-05-08 |
2003-08-11 |
Biochemie Sa |
Improvements in macrolide production
|
CA2245398C
(en)
*
|
1998-08-21 |
2002-01-29 |
Apotex Inc. |
Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
|
EP1115732B1
(en)
|
1998-09-22 |
2005-06-29 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
CA2349338C
(en)
*
|
1998-11-03 |
2005-12-06 |
Pfizer Products Inc. |
Novel macrolide antibiotics
|
UA70972C2
(uk)
*
|
1998-11-20 |
2004-11-15 |
Пфайзер Продактс Інк. |
13-членні азаліди і їх застосування як антибіотиків
|
CN1273142C
(zh)
|
1998-11-30 |
2006-09-06 |
特瓦制药工业有限公司 |
阿齐霉素的乙醇化物,制备方法以及医药组合物
|
EP1137654A1
(en)
|
1998-12-10 |
2001-10-04 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
OA11753A
(en)
*
|
1999-01-27 |
2005-07-19 |
Pfizer Prod Inc |
Ketolide antibiotics.
|
US7056893B2
(en)
*
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
US6939861B2
(en)
*
|
1999-04-16 |
2005-09-06 |
Kosan Biosciences, Inc. |
Amido macrolides
|
AP2001002302A0
(en)
*
|
1999-05-24 |
2001-10-25 |
Pfizer Prod Inc |
13-Methyl erythromycin derivatives.
|
US6465437B1
(en)
*
|
1999-06-30 |
2002-10-15 |
Pfizer Inc. |
Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
|
EP1206476B1
(en)
*
|
1999-08-24 |
2006-01-04 |
Abbott Laboratories |
9a-azalides with antibacterial activity
|
US6764996B1
(en)
|
1999-08-24 |
2004-07-20 |
Abbott Laboratories |
9a-azalides with antibacterial activity
|
EP1101769A3
(en)
|
1999-11-18 |
2001-10-24 |
Pfizer Products Inc. |
Nitrogen containing erythromycin derivatives
|
ES2177373B1
(es)
|
1999-11-26 |
2003-11-01 |
Astur Pharma Sa |
Preparacion de azitromicina en su forma no cristalina
|
PT1246831E
(pt)
|
2000-01-04 |
2008-03-28 |
Teva Pharma |
Método de preparação de di-hidrato de azitromicina
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US20030213724A1
(en)
*
|
2000-03-20 |
2003-11-20 |
Sven Dobler |
Fragrance sampler insert
|
US6403776B1
(en)
|
2000-07-05 |
2002-06-11 |
Pfizer Inc. |
Synthesis of carbamate ketolide antibiotics
|
ATE320441T1
(de)
|
2000-07-25 |
2006-04-15 |
Silanes Sa De Cv Lab |
Einstufiges verfahren zur herstellung von 7,16-
|
US20020115621A1
(en)
*
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
DE60114028T2
(de)
|
2000-08-23 |
2006-07-13 |
Wockhardt Ltd. |
Verfahren zur herstellung von wasserfreiem azithromycin
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
US6949519B2
(en)
|
2000-11-27 |
2005-09-27 |
Sandoz Ag |
Macrolide solvates
|
WO2002088158A1
(en)
|
2001-04-27 |
2002-11-07 |
Pfizer Products Inc. |
Process for preparing 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
|
EP1671979B1
(en)
|
2001-05-22 |
2008-08-13 |
Pfizer Products Inc. |
New Cristal Form of Azithromycin
|
US6861413B2
(en)
*
|
2001-05-22 |
2005-03-01 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
NZ529118A
(en)
|
2001-05-22 |
2005-10-28 |
Pfizer Prod Inc |
Crystal forms of azithromycin
|
EA200400214A1
(ru)
*
|
2001-08-21 |
2004-06-24 |
Пфайзер Продактс Инк. |
Азитромицин в виде разовой дозы
|
US20080149521A9
(en)
*
|
2001-10-18 |
2008-06-26 |
Michael Pesachovich |
Methods of stabilizing azithromycin
|
DE60232005D1
(de)
*
|
2001-10-18 |
2009-05-28 |
Teva Pharma |
Stabilisierte azithromycin-zusammensetzungen
|
IL161259A0
(en)
*
|
2001-12-21 |
2004-09-27 |
Pfizer Prod Inc |
Methods for wet granulating azithromycin
|
NZ532707A
(en)
*
|
2001-12-21 |
2006-07-28 |
Pfizer Prod Inc |
Directly compressible formulations of azithromycin
|
US8063021B2
(en)
*
|
2002-01-17 |
2011-11-22 |
Kosan Biosciences Incorporated |
Ketolide anti-infective compounds
|
NZ534234A
(en)
*
|
2002-02-01 |
2007-05-31 |
Pfizer Prod Inc |
Dry granulated formulations of non-dihydrate form of azithromycin
|
US20040186063A1
(en)
*
|
2002-02-15 |
2004-09-23 |
Hans-Jurgen Gutke |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
US20040005641A1
(en)
*
|
2002-02-15 |
2004-01-08 |
Michael Burnet |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
CA2476423A1
(en)
|
2002-02-15 |
2003-08-28 |
Sympore Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
EP1482957A4
(en)
*
|
2002-02-15 |
2006-07-19 |
Merckle Gmbh |
ANTIBIOTIC CONJUGATES
|
EP1479687A4
(en)
*
|
2002-02-26 |
2006-01-04 |
Meiji Seika Kaisha |
A NEW LOW-GYLIC CYCLIC AZALIDE, A NEW 16-LOW CYCLIC DIAZALID DERIVATIVE AND METHOD FOR THE PRODUCTION THEREOF
|
ITMI20021209A1
(it)
*
|
2002-06-04 |
2003-12-04 |
Chemi Spa |
Processo di preparazione di azitromicina ad elevata purezza
|
WO2003105810A1
(en)
*
|
2002-06-14 |
2003-12-24 |
Andrx Corporation |
Pharmaceutical compositions for drugs having ph-dependentsolubility
|
NZ537717A
(en)
*
|
2002-07-08 |
2006-04-28 |
Pliva Istrazivacki Inst D |
New compounds, compositions and methods for treatment of inflammatory diseases and conditions
|
BR0312584A
(pt)
*
|
2002-07-08 |
2005-04-12 |
Pliva Istrazivacki Inst D O O |
Novas substâncias anti-inflamatórias não-esteróides, compostos e métodos para o uso das mesmas
|
PL375162A1
(en)
*
|
2002-07-08 |
2005-11-28 |
Pliva-Istrazivacki Institut D.O.O. |
Novel compounds, compositions as carriers for steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
|
HRP20020885B1
(en)
*
|
2002-11-11 |
2007-05-31 |
GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. |
SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
|
HRP20020991A2
(en)
*
|
2002-12-12 |
2005-02-28 |
Pliva-Istra�iva�ki institut d.o.o. |
N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
|
ES2552682T3
(es)
|
2003-03-10 |
2015-12-01 |
Merck Sharp & Dohme Corp. |
Agentes antibacterianos novedosos
|
US20040266997A1
(en)
*
|
2003-03-25 |
2004-12-30 |
Michael Pesachovich |
Degradation products of azithromycin, and methods for their indentification
|
ES2220229B1
(es)
*
|
2003-05-29 |
2005-10-16 |
Quimica Sintetica, S.A. |
Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
|
CA2673334C
(en)
*
|
2003-06-16 |
2013-11-12 |
Andrx Pharmaceuticals, Llc |
Oral extended-release composition
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
CA2533292C
(en)
|
2003-07-21 |
2013-12-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
EP1648418A4
(en)
|
2003-07-21 |
2011-11-16 |
Middlebrook Pharmaceuticals Inc |
ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
|
AU2004258949B2
(en)
|
2003-07-21 |
2011-02-10 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
CA2535177A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
EP1653924A4
(en)
|
2003-08-12 |
2009-09-09 |
Middlebrook Pharmaceuticals In |
ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
|
JPWO2005019238A1
(ja)
*
|
2003-08-22 |
2006-10-19 |
明治製菓株式会社 |
新規アザライド及びアザラクタム誘導体とその製造法
|
CA2535780A1
(en)
*
|
2003-08-29 |
2005-03-17 |
Advancis Pharmaceuticals Corporation |
Antibiotic product, use and formulation thereof
|
CN1313476C
(zh)
*
|
2003-09-09 |
2007-05-02 |
上海新先锋药业有限公司 |
阿奇霉素的水溶性磷酸盐的注射剂型及其制备方法
|
US8460710B2
(en)
|
2003-09-15 |
2013-06-11 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
WO2005030227A1
(en)
*
|
2003-09-23 |
2005-04-07 |
Enanta Pharmaceuticals, Inc. |
9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
|
US20050101547A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Sadatrezaei Mohsen |
Stabilized azithromycin composition
|
CA2547597A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate compositions with improved stability
|
MXPA06005913A
(es)
*
|
2003-12-04 |
2006-06-27 |
Pfizer Prod Inc |
Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
EP1689368B1
(en)
|
2003-12-04 |
2016-09-28 |
Bend Research, Inc |
Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
CN1889931A
(zh)
*
|
2003-12-04 |
2007-01-03 |
辉瑞产品公司 |
利用挤压器制备优选含泊洛沙姆和甘油酯的多重粒子阿奇霉素组合物的喷雾-冻凝方法
|
CN1889932A
(zh)
|
2003-12-04 |
2007-01-03 |
辉瑞产品公司 |
制备药用多颗粒的方法
|
US7943585B2
(en)
|
2003-12-22 |
2011-05-17 |
Sandoz, Inc. |
Extended release antibiotic composition
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
EP1782816B1
(en)
*
|
2004-07-02 |
2011-10-19 |
Wakamoto Pharmaceutical Co., Ltd. |
Water-based medicinal composition containing azithromycin and method of preparing the same
|
CA2572292A1
(en)
|
2004-07-02 |
2006-02-09 |
Advancis Pharmaceutical Corporation |
Tablet for pulsed delivery
|
CA2576291A1
(en)
*
|
2004-08-12 |
2006-02-23 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
|
US20060183696A1
(en)
*
|
2004-08-12 |
2006-08-17 |
Pliva-Istrazivacki Institut D.O.O. |
Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
|
US7683162B2
(en)
*
|
2004-08-30 |
2010-03-23 |
Taro Pharmaceutical Industries Limited |
Process of preparing a crystalline azithromycin monohydrate
|
US20060046970A1
(en)
*
|
2004-08-31 |
2006-03-02 |
Insite Vision Incorporated |
Topical otic compositions and methods of topical treatment of prevention of otic infections
|
UA85937C2
(uk)
|
2004-12-21 |
2009-03-10 |
Пфайзер Продактс Інк. |
Макроліди
|
CA2591744A1
(en)
*
|
2004-12-21 |
2006-06-29 |
Pfizer Products Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
US20090318375A1
(en)
|
2005-06-08 |
2009-12-24 |
Hanmi Pharm Co., Ltd |
Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
|
RU2008106915A
(ru)
*
|
2005-07-26 |
2009-09-10 |
Меркле Гмбх (De) |
Макролидные конъюгаты пирролиновых и индолизиновых соединений
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
WO2007091393A1
(ja)
*
|
2006-02-07 |
2007-08-16 |
Taisho Pharmaceutical Co., Ltd. |
10a-アザライド化合物
|
US8299052B2
(en)
*
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US7704959B2
(en)
|
2006-10-03 |
2010-04-27 |
Dow Pharmaceutical Sciences |
Azithromycin for the treatment of nodular acne
|
JPWO2009019868A1
(ja)
|
2007-08-06 |
2010-10-28 |
大正製薬株式会社 |
10a、12位架橋型10a−アザライド化合物
|
US8124123B2
(en)
*
|
2007-09-05 |
2012-02-28 |
Dow Pharmaceutical Sciences, Inc. |
Controlled release azithromycin solid dosages forms
|
EP2214484A4
(en)
|
2007-10-25 |
2013-01-02 |
Cempra Pharmaceuticals Inc |
PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
|
US8299035B2
(en)
|
2008-05-15 |
2012-10-30 |
Taisho Pharmaceutucal Co., Ltd. |
10a-azalide compound having 4-membered ring structure
|
EP2358379B1
(en)
*
|
2008-10-24 |
2015-12-16 |
Cempra Pharmaceuticals, Inc. |
Biodefenses using triazole-containing macrolides
|
US20170128481A9
(en)
|
2009-03-06 |
2017-05-11 |
Insite Vision Corporation |
Ocular treatment with reduced intraocular pressure
|
BRPI1009823A2
(pt)
|
2009-03-13 |
2019-09-24 |
Da Volterra Assistance Publique Hopitaux De Paris E Univ Paris Diderot Paris 7 |
"composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
|
US9937194B1
(en)
|
2009-06-12 |
2018-04-10 |
Cempra Pharmaceuticals, Inc. |
Compounds and methods for treating inflammatory diseases
|
WO2011015219A1
(en)
|
2009-08-06 |
2011-02-10 |
Shifa Pharmed Industrial Group Co. |
Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
|
US9480679B2
(en)
|
2009-09-10 |
2016-11-01 |
Cempra Pharmaceuticals, Inc. |
Methods for treating malaria, tuberculosis and MAC diseases
|
DK2550286T3
(da)
|
2010-03-22 |
2016-02-29 |
Cempra Pharmaceuticals Inc |
Krystallinske former af et macrolid og anvendelser deraf
|
EP2571506B1
(en)
|
2010-05-20 |
2017-05-10 |
Cempra Pharmaceuticals, Inc. |
Processes for preparing macrolides and ketolides and intermediates therefor
|
EP2613630A4
(en)
|
2010-09-10 |
2014-01-15 |
Cempra Pharmaceuticals Inc |
FLUOROCETOLIDES FORMING HYDROGEN LINKS TO TREAT DISEASES
|
AR085286A1
(es)
|
2011-02-21 |
2013-09-18 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrolido sustituido en la posicion c-4
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
KR20140139083A
(ko)
|
2012-03-27 |
2014-12-04 |
셈프라 파마슈티컬스, 인크. |
마크롤라이드계 항생제를 투여하기 위한 비경구 제제
|
US10987370B2
(en)
|
2012-12-24 |
2021-04-27 |
Ramot At Tel-Aviv University Ltd. |
Methods of inducing read-through of a nonsense mutation associated with ataxia telangiectasia, Rett syndrome or spinal muscular atrophy by erythromycin or azithromycin
|
JP6426696B2
(ja)
|
2013-03-14 |
2018-11-21 |
センプラ ファーマシューティカルズ,インコーポレイテッド |
呼吸器疾患の治療のための方法および製剤
|
EP2968384A4
(en)
|
2013-03-15 |
2017-02-15 |
Cempra Pharmaceuticals, Inc. |
Convergent processes for preparing macrolide antibacterial agents
|
US9044508B2
(en)
|
2013-03-15 |
2015-06-02 |
Insite Vision Corporation |
Concentrated aqueous azalide formulations
|
CN103965273B
(zh)
|
2013-08-23 |
2016-05-25 |
普莱柯生物工程股份有限公司 |
一种大环内酯类化合物
|
US20150141328A1
(en)
*
|
2013-11-18 |
2015-05-21 |
The Schepens Eye Research Institute |
Stimulation of human meibomian gland function
|
AR102810A1
(es)
|
2014-08-18 |
2017-03-29 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrólido sustituido en la posición c-4
|
CA3054166A1
(en)
|
2017-02-22 |
2018-08-30 |
Immune System Regulation Holding Ab |
Novel immune stimulating macrolide
|
EP3585794B1
(en)
|
2017-02-22 |
2020-12-23 |
ISR Immune System Regulation Holding AB (publ) |
Novel immune stimulating compound
|
EP4208172A1
(en)
|
2020-09-03 |
2023-07-12 |
ISR Immune System Regulation Holding AB (publ) |
Vaccine comprising an antigen and a tlr2 agonist
|